Establishment Historical Balance Sheet
ESTA Stock | USD 52.99 0.31 0.58% |
Trend analysis of Establishment Labs Holdings balance sheet accounts such as Short and Long Term Debt Total of 201.8 M or Other Current Liab of 14.5 M provides information on Establishment Labs' total assets, liabilities, and equity, which is the actual value of Establishment Labs to its prevalent stockholders. By breaking down trends over time using Establishment Labs balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Establishment Labs latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Establishment Labs is a good buy for the upcoming year.
Establishment Labs Inventory |
|
Establishment |
About Establishment Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Establishment Labs at a specified time, usually calculated after every quarter, six months, or one year. Establishment Labs Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Establishment Labs and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Establishment currently owns. An asset can also be divided into two categories, current and non-current.
Establishment Labs Balance Sheet Chart
Establishment Labs Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Establishment Labs uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, Establishment Labs' Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 14.5 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 21.8 M. Add Fundamental
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Total Assets
Total assets refers to the total amount of Establishment Labs assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Establishment Labs books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Establishment Labs balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Establishment Labs Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from Establishment Labs' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Establishment Labs current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. At present, Establishment Labs' Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 14.5 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 21.8 M.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 53.8M | 178.7M | 192.2M | 201.8M | Total Assets | 139.5M | 211.1M | 268.6M | 150.6M |
Establishment Labs balance sheet Correlations
Click cells to compare fundamentals
Establishment Labs Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Establishment Labs balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 20.5M | 23.3M | 24.0M | 24.5M | 25.6M | 21.8M | |
Total Assets | 116.5M | 156.4M | 139.5M | 211.1M | 268.6M | 150.6M | |
Short Long Term Debt Total | 48.1M | 51.8M | 53.8M | 178.7M | 192.2M | 201.8M | |
Other Current Liab | 11.8M | 14.0M | 16.2M | 16.5M | 12.9M | 14.5M | |
Total Current Liabilities | 23.2M | 25.9M | 31.9M | 39.0M | 57.2M | 30.6M | |
Total Stockholder Equity | 39.6M | 75.0M | 50.7M | (8.2M) | 18.4M | 29.4M | |
Other Liab | 5.5M | 3.8M | 3.1M | 1.6M | 1.5M | 1.4M | |
Net Tangible Assets | 35.7M | 70.3M | 45.9M | (13.3M) | (15.2M) | (14.5M) | |
Property Plant And Equipment Net | 16.4M | 18.8M | 20.9M | 54.8M | 80.6M | 84.6M | |
Current Deferred Revenue | 785K | 1.2M | 769K | 1.7M | 1.8M | 1.5M | |
Net Debt | 10.5M | (32.8M) | 391K | 112.3M | 152.2M | 159.8M | |
Retained Earnings | (127.1M) | (165.2M) | (206.4M) | (281.6M) | (360.1M) | (342.1M) | |
Accounts Payable | 10.4M | 9.7M | 14.5M | 20.0M | 41.6M | 43.7M | |
Cash | 37.7M | 84.5M | 53.4M | 66.4M | 40.0M | 47.6M | |
Non Current Assets Total | 20.7M | 24.1M | 26.3M | 61.2M | 93.7M | 98.4M | |
Non Currrent Assets Other | 368K | 664K | 558K | 1.3M | 4.7M | 4.9M | |
Other Assets | 368K | 664K | 558K | 1.3M | 1.5M | 785.7K | |
Cash And Short Term Investments | 37.7M | 84.5M | 53.4M | 66.4M | 40.0M | 47.6M | |
Net Receivables | 22.8M | 19.1M | 24.4M | 35.4M | 46.9M | 25.6M | |
Common Stock Total Equity | 147.7M | 213.5M | 219.7M | 223.6M | 257.2M | 156.9M | |
Liabilities And Stockholders Equity | 116.5M | 156.4M | 139.5M | 211.1M | 268.6M | 150.6M | |
Non Current Liabilities Total | 53.7M | 55.5M | 56.9M | 180.3M | 193.1M | 202.8M | |
Capital Surpluse | 21.2M | 26.7M | 36.6M | 49.9M | 57.4M | 60.3M | |
Inventory | 28.7M | 23.2M | 28.4M | 36.6M | 79.9M | 83.9M | |
Other Current Assets | 1.3M | 2.6M | 2.6M | 11.5M | 8.0M | 4.6M | |
Other Stockholder Equity | 18.4M | 23.9M | 33.7M | 47.1M | 60.9M | 63.9M | |
Total Liab | 76.9M | 81.4M | 88.8M | 219.2M | 250.2M | 262.8M | |
Property Plant And Equipment Gross | 16.4M | 18.8M | 20.9M | 54.8M | 96.9M | 101.8M | |
Total Current Assets | 95.8M | 132.3M | 113.3M | 149.9M | 174.9M | 112.4M | |
Accumulated Other Comprehensive Income | 691K | 2.9M | 3.7M | 2.7M | 2.0M | 1.5M | |
Non Current Liabilities Other | 336K | 2.3M | 2.4M | 175.5M | 147K | 139.7K | |
Short Term Debt | 258K | 948K | 402K | 688K | 773K | 734.4K | |
Intangible Assets | 3.4M | 4.1M | 4.4M | 4.6M | 8.0M | 4.6M | |
Common Stock | 147.7M | 213.5M | 219.7M | 223.6M | 315.6M | 180.7M | |
Property Plant Equipment | 16.4M | 16.2M | 20.9M | 51.1M | 58.8M | 61.7M | |
Long Term Debt | 48.1M | 49.8M | 51.9M | 175.5M | 188.7M | 198.2M | |
Net Invested Capital | 87.8M | 124.8M | 102.6M | 175.5M | 207.1M | 127.1M | |
Net Working Capital | 72.6M | 106.4M | 81.4M | 110.9M | 117.8M | 87.1M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Establishment Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Establishment Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Establishment Labs Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Establishment Labs Holdings Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Establishment Stock analysis
When running Establishment Labs' price analysis, check to measure Establishment Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Establishment Labs is operating at the current time. Most of Establishment Labs' value examination focuses on studying past and present price action to predict the probability of Establishment Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Establishment Labs' price. Additionally, you may evaluate how the addition of Establishment Labs to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Establishment Labs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.17) | Revenue Per Share 5.906 | Quarterly Revenue Growth (0.20) | Return On Assets (0.16) | Return On Equity (4.05) |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.